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The reliable production of marine fish larvae is one of the major bottlenecks in aquaculture due to high 
mortalities mainly caused by infectious diseases. To evaluate if the compound poly-β-hydroxybutyrate 
(PHB) might be a suitable immunoprophylactic measure in fish larviculture, its capacity to improve 
immunity and performance in European sea bass (Dicentrarchus labrax) yolk-sac larvae was explored. 
PHB was applied from mouth opening onwards to stimulate the developing larval immune system at 
the earliest possible point in time. Larval survival, growth, microbiota composition, gene expression 
profiles and disease resistance were assessed. PHB administration improved larval survival and, 
furthermore, altered the larva-associated microbiota composition. The bacterial challenge test using 
pathogenic Vibrio anguillarum revealed that the larval disease resistance was not influenced by PHB. 
The expression profiles of 26 genes involved e.g. in the immune response showed that PHB affected 
the expression of the antimicrobial peptides ferritin (fer) and dicentracin (dic), however, the response 
to PHB was inconsistent and weaker than previously demonstrated for sea bass post-larvae. Hence, the 
present study highlights the need for more research focusing on the immunostimulation of different 
early developmental stages for gaining a more comprehensive picture and advancing a sustainable 
production of high quality fry.
In marine aquaculture, the stable and cost-effective production of high quality fish larvae is still hampered due to 
low survival during larval rearing, mainly caused by infectious diseases1,2. Early life stages of fish are highly sus-
ceptible to pathogens, because their immunocompetence is still severely limited3. For many aquaculture-relevant 
fish species, it has been reported that maternally-transferred immune molecules become mostly depleted during 
the first couple of days after hatch4–7. In European sea bass larvae, for example, maternal IgM was not detectable 
anymore by day 5 post hatch8. Accordingly, fish larvae mainly rely on their innate immune response, while adap-
tive immunity still needs to be acquired9,10. As a consequence, vaccines are not applicable during larval stages, 
as their effect depends on immunological memory, a feature of adaptive immunity11. Moreover, the standard 
method to combat diseases with antibiotics has selected for antibiotic-resistant bacteria, making treatments less 
effective and additionally being a risk to the environment and the human health12. Hence, investigating new bio-
control agents for disease prevention is crucial to evolve a sustainable aquaculture industry with enhanced larval 
survival rates and, therefore, reduced economic losses13. An alternative method is the stimulation of the immune 
response in fish larvae to improve their health and, thus, prevent the outbreak of diseases14,15.
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A potential biocontrol strategy is the application of poly-β-hydroxybutyrate (PHB), the polymer of the 
short-chain fatty acid (SCFA) β-hydroxybutyrate (β-HB)16. PHB is an energy storage compound accumulated 
by a wide range of bacterial genera such as Alcaligenes and Bacillus17,18. In various aquatic organisms, including 
shrimps (Penaeus monodon)19, rainbow trout (Oncorhynchus mykiss)20 and European sea bass (Dicentrarchus 
labrax) juveniles21, PHB has been demonstrated to increase survival and growth. Furthermore, dietary PHB 
increased the gastrointestinal (GI) microbial species evenness, diversity and richness in European sea bass juve-
niles and Siberian sturgeon (Acipenser baerii) fingerlings, which is suggested to contribute to a decreased infec-
tion risk22,23. The compound can be intestinally degraded into SCFAs, thereby, lowering the pH in the host’s 
gut21. While beneficial bacteria such as lactic acid bacteria profit from a lower intestinal pH, it has been shown 
that the cell growth and multiplication of pathogenic bacteria like Vibrio spp. is suppressed by SCFAs24,25. A 
disease protecting effect of PHB has been demonstrated, for example, in Artemia franciscana26, Chinese mitten 
crab (Eriocheir sinensis) larvae27 and gnotobiotic Nile tilapia (Oreochromis niloticus) larvae28. Since SCFAs are 
known to play a central role in mammalian immunity, it is hypothesized that β-HB is capable of modulating the 
immune response in fish29. However, in teleosts PHB has so far only been shown to enhance the expression of 
immune-related genes in sea bass post-larvae30 and serum immune parameters as well as antibody response in 
adult Mozambique tilapia (Oreochromis mossambicus)31.
In the current study, it was investigated if the application of PHB modulates the immune response and 
the microbial community in European sea bass yolk-sac larvae. The aim was to stimulate the developing lar-
val immune system at the earliest possible point in time. Therefore, freeze-dried PHB-accumulated bacteria 
(Alcaligenes eutrophus) were administered to sea bass larvae from mouth opening onwards and the effect on larval 
survival, growth performance, microbiota and disease resistance was assessed. Furthermore, an extensive analysis 
on the expression of genes involved in immunity, metabolism, growth and stress was performed.
Materials and Methods
Larval rearing. European sea bass (Dicentrarchus labrax) larvae were purchased from a commercial hatchery 
(Ecloserie Marine de Gravelines, France) at 3 dph and randomly distributed over 15 green tanks (100 larvae L−1) 
at GEOMAR Kiel, Germany. Each tank was filled with 30 L Baltic Sea water (5 μm-filtered and UV-treated) with 
an artificially increased salinity of 32 g L−1, which was gradually decreased to 26 g L−1 until 14 dph and increased 
to 32 g L−1 again thereafter to improve the efficiency of swim bladder inflation32. The water flow was gradually 
increased from 0.05 to 0.1 L min−1 until the end of the experimental period at 22 dph. The water temperature was 
increased stepwise from 15 to 18 °C and oxygen was maintained above 89% saturation throughout the experi-
ment. Larvae were kept in the dark until first feeding at 8 dph and thereafter under a natural photoperiod regime 
(16 L: 8D). Tank bottoms were siphoned daily to remove dead larvae, feces and debris.
Experimental treatments and feeding. Two different PHB doses (low and high) were administered from 
2 different points in time onwards (mouth opening and first feeding), respectively, resulting in the following 
treatments: (1) Low PHB dose administered from mouth opening onwards (LMO), (2) Low PHB dose from first 
feeding onwards (LFF), (3) High PHB dose from mouth opening onwards (HMO), (4) High PHB dose from first 
feeding onwards (HFF) and (5) No PHB administration (Control). Each treatment was triplicated.
Amorphous PHB was administered in the form of freeze-dried PHB-accumulated bacteria (Alcaligenes eutro-
phus) produced by VITO (Mol, Belgium) as described in Thai et al. (2014)33. Bacteria with 2.5% and 75% PHB 
on cell dry weight (lowest and highest PHB accumulation possible for A. eutrophus) were used to prepare PHB 
solutions that were added to the tank water directly and used to enrich rotifers, respectively. From mouth open-
ing (MO) at 5 dph onwards, PHB at a low or high dose was added directly to the tank water of the treatments 
LMO and HMO, respectively. For this purpose, the freeze-dried PHB-accumulated bacteria were suspended in 
UV-treated sea water with a salinity of 32 g L−1 and the PHB solutions were added daily at 10:00 h at a concentra-
tion of 106 bacteria mL−1 tank water until the end of the experiment (22 dph). The water flow was turned off from 
10:00 h to 18:00 h. Furthermore, all PHB treatments (LMO, HMO, LFF and HFF) were fed with PHB-enriched 
rotifers (Brachionus plicatilis) from first feeding (FF) at 8 dph onwards over a period of 14 days. The control 
treatment was fed on rotifers that were not enriched with PHB. Rotifers were reared in sterile filtered Baltic Sea 
water, fed on resuspended Nannochloropsis spp. concentrate and enriched with essential fatty acids (S.presso, 
INVE, applied according to instructions). Sea bass larvae were fed 3 times a day at 10:00 h, 15:00 h and 20:00 h 
(feeding ratio = 2:1:1). The rotifer density was increased over the course of the experiment from 4 to 12 rotifers 
mL−1 (first meal) and 2 to 6 rotifers mL−1 (second and third meal, respectively). For the PHB treatments, rotifers 
were enriched in freshly prepared PHB solutions at a density of 1000 ind. mL−1 for 30 min under gentle aeration 
directly before feeding. The PHB solutions for the rotifer enrichment consisted of freeze-dried PHB-accumulated 
bacteria with a low and high PHB content, respectively, suspended in sea water (UV-treated, salinity 32 g L−1) at 
a concentration of 108 bacteria mL−1.
Growth performance and survival. At 22 dph, 10 larvae were randomly sampled from each tank, killed 
with an overdose of MS 222, transferred into Eppendorf vials with sea water and immediately frozen on dry 
ice. Samples were stored at −80 °C. For growth analysis the total length (mm) of thawed larvae was measured. 
Afterwards larvae were briefly rinsed in distilled water to avoid salt residues, freeze-dried for 18 h at −55 °C and 
weighed in order to determine the larval dry weight (µg).
Furthermore, Fulton’s condition factor (K) was calculated according to equation (1):
=K W
L3
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where W equals the dry weight (µg) and L the total length (mm) of the larvae. For calculating survival rates, dead 
larvae were removed daily from the tanks and counted.
Gene expression analysis. At 11 dph 18 larvae and at 22 dph 6 larvae were randomly sampled from each 
tank, killed with an overdose of MS 222, transferred into RNAlater and kept at 4 °C for 24 h before being stored 
at −20 °C. These 2 sampling points were chosen to assess short-term and mid-term effects of PHB administra-
tion on sea bass yolk-sac larvae. For the quantification of mRNA as a measure of gene expression levels, RNA of 
whole larvae was extracted using the RNeasy 96 Universal Tissue Kit (Qiagen) according to the manufacturer’s 
instructions. At 11 dph single larvae were too small to obtain enough RNA for gene expression measurements. 
Therefore, 6 × 3 larvae were pooled per tank for RNA extraction. At 22 dph 6 single larvae per tank were used. 
The RNA concentration was measured by spectrophotometry and normalized to a common concentration with 
RNase free water. RNA (500 ng) was reverse transcribed into cDNA, including a gDNA wipeout step (QuantiTect 
Reverse Transcription Kit, Qiagen). The cDNA was stored at −80 °C until further use. Primers for all genes were 
designed with Primer3 (version 0.4.0) using D. labrax sequences from GenBank or taken from the literature34,35 
(Table 1). A qPCR BioMark™ HD System (Fluidigm) running a 96.96 Dynamic Array™ IFC (Gene Expression 
chip) was used to measure the expression profiles of 26 target genes as well as 3 reference genes in the larval sam-
ples. The chip run was performed using the GE Fast 96 × 96 PCR + Melt v2 thermal cycling protocol with a Tm 
of 60 °C according to the manufacturer´s instructions. For primer sequences, details on primer testing and the 
preparation of the Gene Expression chip see Franke et al. (2017)30.
Larva-associated microbiota analysis. At 22 dph, 5 larvae were randomly sampled from each tank, 
killed with an overdose of MS 222, transferred into ethanol and stored at 4 °C. Since the larvae were too small 
to remove the intestinal tract, whole single larvae were used for DNA extraction (DNeasy 96 blood & tissue kit, 
Qiagen). Extracted DNA was stored at −20 °C until further use. For the 16S rRNA gene-based characterization 
of the larva-associated microbiota, DNA including a negative and a positive (Vibrio sp.) control was amplified 
(Phusion High-Fidelity DNA Polymerase, Thermo Fisher Scientific) using the primers F515 and R806 for the 
variable region 4 of the 16S rRNA gene36. Both primers contained adapters, barcodes, pad and linker sequences 
as described by Kozich et al. (2013)37. PCR cycling conditions for DNA amplification were as follows: 98 °C for 
30 sec, followed by 30 cycles of 98 °C for 9 s, 55 °C for 15 sec and 72 °C for 20 sec, followed by 10 min at 72 °C. 
To eliminate primer dimers, the PCR products were purified using a MinElute 96 UF PCR purification kit 
(Qiagen). Subsequently, the DNA concentration of every sample was measured by spectrophotometry. Approx. 
30 ng DNA per sample were pooled and a gel extraction was conducted (NucleoSpin gel and PCR clean-up kit, 
Macherey-Nagel). The extraction products were fluorometrically quantified (Qubit fluorometer, Invitrogen) and 
then pooled in equimolar amounts. Thereafter, the purified 16S rRNA amplicons were sequenced on a MiSeq 
sequencer (Illumina) as described in Kozich et al. (2013)37. MiSeq sequence data were assembled and filtered 
using mothur (version 1.16.1)37. Sequence reads were merged and aligned against the SILVA alignment database 
(release 119), all sequences that did not cover the variable region 4 were removed (SILVA alignment position 
1968 to 11550)38. To reduce sequencing noise, a preclustering step (2 bp difference) was performed39 and chimeric 
sequences were removed using UCHIME as implemented in mothur40. The taxonomy of all sequences was esti-
mated using the classify.seqs function in mothur against the RDP database41 using a bootstrap cutoff of 80%. The 
sequences were clustered at the 0.03 difference level to obtain operational taxonomic units (OTUs). Data have 
been submitted to the NCBI Sequence Read Archive under BioProject ID PRJNA384697. Furthermore, species 
richness, Simpson’s evenness and inverse Simpson’s diversity were calculated in mothur based on a dataset sub-
sampled to a number of 10,000 reads per sample.
Bacterial challenge test. In order to investigate the protective effect of PHB against vibriosis, sea bass lar-
vae were exposed to pathogenic Vibrio anguillarum in a bath challenge. Therefore, 100 larvae were taken out of 
each tank (all treatments) at 22 dph and randomly distributed over 2 aquaria with a volume of 1.5 L (resulting in 
50 larvae per aquaria). One aquarium was used for the bacterial challenge test (group BC) and the other one as an 
unchallenged control group (group UC). The experimental conditions were as follows: temperature 18 °C, salinity 
32 g L−1, sea water was 5µm-filtered and UV-treated, photoperiod 16 L: 8D. The virulent V. anguillarum strain 
87-9-117 was obtained from the Laboratory of Aquaculture and Artemia Reference Center (Ghent, Belgium) and 
preserved in 25% glycerol at −80 °C. Bacteria were cultured on 101 nutrient agar overnight at 25 °C. Subsequently, 
single colonies were picked and grown in 101 nutrient broth overnight at 25 °C and 200 rpm in an incubator 
shaker. Bacteria were harvested by centrifugation at 644 g for 10 min, washed twice in filtered and autoclaved sea 
water with a salinity of 32 g L−1 and added to the rearing water of group BC at a final density of 107 CFU mL−1. 
After 24 h of challenge, the tank water was completely replaced in all aquaria. Afterwards the water flow was 
turned on overnight at a flow rate of 0.01 L min−1. The survival of the sea bass larvae was monitored over a period 
of 4 days. Larvae were not fed over the course of the experiment and dead larvae were removed daily.
Enrichment of rotifers with 13 C labeled PHB-accumulated bacteria. To confirm bioencapsulation 
of the PHB-accumulated bacteria into the rotifers, bacteria had been labeled with 13 C during the accumulation 
of PHB into their biomass. To achieve 13 C labeling of the bacteria, they were produced by VITO (Mol, Belgium) 
as described in Thai et al. (2014)33 with the modification that 13 C labeled D-glucose (U-13CS, 99%, Eurisotop, 
France) was used as a carbon source for PHB accumulation. Subsequently, rotifers were enriched with the 13C 
labeled PHB-accumulated bacteria suspended in sea water (UV-treated, salinity 32 g L−1) at a density of 1000 
rotifers mL−1 for 30 min under gentle aeration (rotifers without adding 13 C labeled PHB-accumulated bacteria 
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were used as a control). After enrichment, rotifers were rinsed with Milli-Q water on a 50 µm sieve, transferred 
into tin foil cups and dried at 60 °C in a drying cabinet. Carbon isotope composition analysis of the samples was 
performed by isotope ratio mass spectrometry.
Use of experimental animals. All experiments were approved by the ethical committee of Kiel University 
(Germany) under the file number V 312-7224.121-19 (24-2/13) and performed in accordance with the relevant 
guidelines and regulations.
Statistical analyses. All statistical analyses were carried out in RStudio (version 0.98.1103). Survival data 
from the main experiment and the bacterial challenge test are presented by means of Kaplan-Meier curves and 
compared between treatment groups using a log-rank test (survival package)42. Post-hoc pairwise comparisons 
were performed in order to determine statistical differences between the respective treatments.
To analyze growth data, a mixed effect model, which included treatment as a fixed factor and tank as a random 
factor, was used (lme4 package)43. Growth data were tested for normality (Shapiro-Wilk test) and homogeneity of 
variances (Levene’s test). If the test assumptions were violated, data were Box-Cox transformed.
For gene expression analysis, the technical triplicates were used to calculate the mean cycle threshold value 
(Ct), the standard deviation (SD), and the coefficient of variation (CV) per sample. Samples with a CV larger 
than 4% were excluded from the analysis, as in accordance with Bookout and Mangelsdorf44. The expression 
stability of genes was calculated using qbase+ (Biogazelle) and the geometric mean Ct of the 3 most stable genes 
(reference genes actb, l13a, hsp90; M <0.5) was used to normalize the target genes (calculation of ΔCt-values). 
Permutational multivariate analyses of variance (PERMANOVA) were performed for each functional gene group 
to test for overall differences between the treatments. PERMANOVAs using ΔCt-values are based on Pearson 
distance matrices and were run with 999 permutations (adonis and Dist function, vegan and amap package)45,46. 
Group Abbreviation Gene name and function Acc. No./Ref.
Immunity
Innate immunity
apoA1 Apolipoprotein A1, antimicrobial protein 35
cc1 CC chemokine 1, chemotactic cytokine AM490065.1
cox2 Cyclo-Oxygenase-2, pro-inflammatory enzyme AJ630649.1
ifna1 Interferon, cytokine AM765846.2
il1b Interleukin 1 beta, pro-inflammatory cytokine AJ311925.1
il8 Interleukin 8, pro-inflammatory cytokine AM490063.1
dic Dicentracin, antimicrobial peptide AY303949.1
fer Ferritin, antimicrobial peptide 35
tlr1 Toll-like receptor 1, pattern recognition receptor KX399287
tlr9 Toll-like receptor 9, pattern recognition receptor KX399289
tnfa Tumor necrosis factor α, pro-inflammatory cytokine DQ070246.1
Adaptive immunity
mhc class Ia Major Histocompatibility Complex I α, cell surface molecules JX171695.1
mhc class IIa Major Histocompatibility Complex II α, cell surface molecules FN667955.1
mhc class IIb Major Histocompatibility Complex II ß, cell surface molecules AM113471.1
rag1 Recombination activating protein 1, involved in VDJ recombination FN687463.1
Complement system
c3 Complement Component C3, classical & alternative pathway HM563078.1
cla C-Lectin-A, lectin pathway EU660935.1
gal Galectin, lectin pathway EU660937.1
Apoptosis
casp3 Caspase 3, protease DQ345773.1
casp9 Caspase 9, protease DQ345776.1
Growth & 
metabolism
gh Growth hormone GQ918491.1
igf1 Insulin-like growth factor 1 AY800248.1
fad6 Fatty acid desaturase-6, fatty acid synthesis FP671139.1
tryp Trypsin, protease AJ006882.1
Stress
cat Catalase, antioxidant FJ860003.1
hsp70 Heat shock protein 70, stress protection AY423555.2
Reference
actb Beta-actin AJ537421.1
l13a Ribosomal protein L13 a 34
hsp90 Heat shock protein 90 AY395632.1
Table 1. Name, abbreviation and function of the 26 genes of interest and 3 reference genes. Genes were divided 
into the following functional groups: (I) immunity, (II) growth and metabolism, (III) stress. Primers were either 
designed using sequences from GenBank (see accession number) or taken from literature (see reference).
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Multivariate effects were assessed on data averaged within an experimental tank. Subsequently, a mixed-effect 
model, which included treatment as a fixed factor and tank as a random factor, was used to analyze each individ-
ual target gene. Data were tested for normality (Shapiro-Wilk test) and homogeneity of variances (Levene’s test). 
If the test assumptions were violated, data were Box-Cox transformed.
Post-hoc pairwise comparisons were performed using the lsmeans function (lsmeans package)47. For graphi-
cal representation of gene expression data in response to PHB, the 2−ΔΔCt method48 was applied by calculating the 
ΔΔCt for each target gene in relation to the mean ΔCt of the respective target gene in the untreated control. For 
graphical representation of the expression of all 26 target genes over the larval development, the 2−ΔCt method49 
was applied by using expression data of the untreated control only.
The microbiota data could not be analyzed for the whole data set due to an insufficient number of reads for 
many larval samples. Only samples with >10,000 reads were included in the statistical analysis, lowering the 
sample size to 1 to 4 larvae per tank and making it difficult to account for a potential tank effect. Hence, tank was 
not implemented in the statistical analyses, instead only treatment was included as a fixed factor using each larva 
instead of each tank as a replicate. To test for differences in the microbial community compositions between the 
treatments, bacterial phyla and OTUs were analyzed performing PERMANOVAs based on Euclidean distance 
matrices (adonis and vegdist function, vegan package, 999 permutations)45. In addition, a principle component 
analysis (PCA) for graphical visualization was implemented based on differences in the bacterial phyla composi-
tion according to the PHB treatments (ade4 package)50. To analyze the species richness, Simpson’s evenness and 
inverse Simpson’s diversity, analyses of variance (ANOVA) were performed (stats package)51.
Data availability. Microbiota data have been submitted to the NCBI Sequence Read Archive under 
BioProject ID PRJNA384697. All other datasets generated and analyzed during the study are available at https://
doi.pangaea.de/10.1594/PANGAEA.876665.
Results
Survival and growth performance. Around first feeding (8 dph), the larval mortality was highly variable 
between the tanks across all treatments. Therefore, differences in survival were only examined after the onset 
of exogenous feeding. The treatments were significantly different from each other (χ2 = 175, df = 4, p < 0.001, 
Fig. 1). Larval survival in treatments LMO, HMO and HFF was significantly higher than in the control treatment 
(χ2LMO = 37, χ2HMO = 134, χ2HFF = 56, df = 1, p < 0.001) while LFF and control (χ2LFF = 1.1, df = 1, p = 0.30) were 
not significantly different from each other. Treatment HMO exhibited the highest survival rate.
The estimated growth-related parameters such as total length (mm), dry weight (µg) and Fulton’s condition 
factor K (µg mm−3) were not affected by the PHB treatment over the course of the experiment. The results are 
presented in Table 2.
Gene expression. The expression of 26 genes involved in immune response, apoptosis, growth, metabolism, 
antioxidant activity and stress-response were analyzed and classified into the following functional gene groups: 
(I) immunity, (II) growth and metabolism, (III) stress. All genes included in the study (Table 1) were expressed at 
11 and 22 dph (Suppl. Fig. S1).
The multivariate analysis showed that the expression of the immune-related genes differed significantly 
between the treatments at 11 dph (F4,10 = 5.0, p < 0.05) and 22 dph (F4,10 = 2.8, p < 0.05), while the other func-
tional gene groups were not affected by the administration of PHB (Suppl. Table S1).
The subsequent univariate analyses (Suppl. Table S2) revealed that the impact of PHB on immune-related 
genes was driven by ferritin expression at 11 dph (F4,10 = 4.0, p < 0.05, Fig. 2A) and the dicentracin expression 
at 22 dph (F4,10 = 3.6, p < 0.05; Fig. 2B). The expression of ferritin was significantly down-regulated in treatment 
LFF (0.7 ± 0.07-fold, ΔCt = 2.6 ± 0.22) compared to the control (1.0 ± 0.04-fold, ΔCt = 1.8 ± 0.09). At this point 
Figure 1. PHB administration enhances survival of sea bass larvae. Depicted are Kaplan-Meier survival curves 
of sea bass larvae (10 to 22 dph) administered a low PHB dose from mouth opening onwards (LMO), a low PHB 
dose from first feeding onwards (LFF), a high PHB dose from mouth opening onwards (HMO), a high PHB 
dose from first feeding onwards (HFF) or no PHB (control), respectively. The dashed lines represent the 95% 
confidence intervals.
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in time (11 dph), the treatment LFF corresponded to 3 days of a low PHB dose encapsulated in the live feed. 
All other treatments were not statistically different from the control. The dicentracin expression was signifi-
cantly decreased in treatment LMO (0.8 ± 0.08-fold, ΔCt = 3.0 ± 0.18) compared to the control (1.1 ± 0.11-fold, 
ΔCt = 2.5 ± 0.13). At this point in time (22 dph), the treatment LMO corresponded to 17 days of a low PHB dose 
administered via the tank water and 14 days of PHB encapsulated in the live feed. All other treatments were not 
statistically different from the control.
Larva-associated microbiota. While the bacterial phyla composition differed significantly between the 
treatments (F4,27 = 1.9, p < 0.05, Fig. 3A and B), there was no difference at the OTU level (F4,27 = 1.0, p = 0.53). 
Bacteria belonging to the phyla Proteobacteria and Bacteroidetes accounted for more than 92.4% of the micro-
biota in all treatments except for LMO where they represented 74.5%. While unclassified bacteria accounted 
for 18.6% in the group LMO, they represented <3.7% in all other experimental groups. The phylum Firmicutes 
accounted for 2.5% and 1.3% of the bacterial community in the treatments HMO and LMO, respectively, while 
it was less than 0.8% in the all other groups (Fig. 3C). The species richness, Simpson’s evenness and inverse 
Simpson’s diversity were not affected by the PHB treatment (Table 3).
Growth-related 
parameters
22 dph (end of experiment)
Control LMO LFF HMO HFF F p
Dry weight (µg) 314 ± 18 386 ± 32 332 ± 25 378 ± 25 364 ± 23 0.7 0.61
Total length (mm) 8.0 ± 0.1 8.3 ± 0.2 8.2 ± 0.1 8.4 ± 0.2 8.4 ± 0.1 0.5 0.72
Condition1 (µg mm−3) 0.61 ± 0.03 0.63 ± 0.03 0.58 ± 0.03 0.62 ± 0.02 0.61 ± 0.03 0.6 0.66
Table 2. Growth-related parameters of sea bass larvae administered a low PHB dose from mouth opening 
onwards (LMO), a low PHB dose from first feeding onwards (LFF), a high PHB dose from mouth opening 
onwards (HMO), a high PHB dose from first feeding onwards (HFF) or no PHB (control), respectively.  
10 larvae per tank were sampled at 22 dph. Values represent mean ± SEM. Furthermore, the mixed-effect model 
results are shown (F-value and p-value; degrees of freedom/residual degrees of freedom for all parameters: 
4/10). 1Fulton’s condition factor K = (W/L3).
Figure 2. PHB affects the expression of (A) ferritin (fer) at 11 dph and (B) dicentracin (dic) at 22 dph in sea 
bass larvae. A low PHB dose from mouth opening onwards (LMO), a low PHB dose from first feeding onwards 
(LFF), a high PHB dose from mouth opening onwards (HMO), a high PHB dose from first feeding onwards 
(HFF) or no PHB (control) was administered, respectively. The figure displays the x-fold gene expression to 
the control. Data are presented as mean ± SEM. Treatments with different letters are significantly different at 
p < 0.05.
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Bacterial challenge test. Unchallenged sea bass larvae survived significantly better than larvae challenged 
with the Vibrio anguillarum strain 87-9-117 (χ2 = 900, df = 1, p < 0.001). The survival of the V. anguillarum chal-
lenged larvae differed from each other (χ2 = 10, df = 4, p < 0.05), however, there was no difference between the 
control group (no PHB) and the PHB treated groups (Suppl. Table S3). Solely, the survival of group LMO dif-
fered significantly from the groups HMO (χ2 = 6, df = 1, p ≤ 0.01) and HFF (χ2 = 5, df = 1, p < 0.05, Fig. 4), 
respectively.
Enrichment of rotifers with 13 C labeled PHB-accumulated bacteria. The carbon isotope compo-
sition analysis revealed that rotifers supplemented with 13 C labeled PHB-accumulated bacteria had an average 
δ13 C value of 2635.6 ± 228.3‰ (SEM) confirming that they were highly enriched with PHB-accumulated bac-
teria. In contrast, rotifers not enriched with 13 C labeled PHB-accumulated bacteria had an average δ13 C value 
of −30.5 ± 0.1‰ (SEM).
Figure 3. PHB controls the bacterial phyla composition in European sea bass larvae. (A) PCA plot visualizing 
the bacterial phyla composition in sea bass larvae (22 dph) administered a low PHB dose from mouth opening 
onwards (LMO), a low PHB dose from first feeding onwards (LFF), a high PHB dose from mouth opening 
onwards (HMO), a high PHB dose from first feeding onwards (HFF) or no PHB (control), respectively. (B) The 
corresponding scatterplot represents the contribution of each variable (bacterial phyla) to the total variability. 
Principle component 1 retains 15.5% and principle component 2 retains 12.9% of variance. (C) Percentage of 
different bacterial phyla in European sea bass larvae.
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Discussion
In the present study, the effects of the bacterial energy storage compound PHB on sea bass yolk-sac larvae were 
examined with respect to survival, growth performance, immunity, microbial community and disease resist-
ance. The larval stage is the most vulnerable of the life cycle stages52,53, suffering from highly variable mortality 
rates especially during critical developmental periods such as first feeding54. Fish larvae depend mainly on their 
innate immune response since their adaptive immune system is still developing, making them extremely sus-
ceptible to infections55. The maturation of the immune system is influenced by the intestinal microbiota, which 
starts to build up from mouth opening onwards and was shown to be altered by PHB supplementation22,23,56,57. 
Accordingly, the focus of this study was to investigate the impact of PHB on the developing larval immune system 
and microbiota, when administered at the earliest possible point in time (mouth opening).
In the present study, the survival was highly variable between the tanks independently of the respective treat-
ment around the onset of first feeding. Similar results were obtained in another study with sea bass larvae where 
the highest mortality rates occurred between 6 and 10 dph around the initiation of exogenous feeding58. As this 
variability would have masked any treatment effect, survival was statistically assessed only at the end of the critical 
first feeding period. The survival was significantly higher in the treatments LMO, HMO and HFF compared to 
the control whereby the administration of PHB in a high dose from mouth opening onwards (HMO) resulted 
in the best larval survival. The larval growth performance was not significantly affected by PHB administration. 
However, there was a trend towards a higher larval weight in all PHB treatments compared to the control. Larvae 
that received either a low or high PHB dose from mouth opening onwards (LMO and HMO) tended to have high-
est weights at the end of the experiment. Treatments LMO and HMO were the only experimental groups being 
provided with PHB via the tank water before larvae were able to feed. These results indicate that the ingestion of 
PHB before the onset of first feeding through drinking has the potential to increase the performance of sea bass 
larvae (either by providing energy or indirectly by changing the intestinal microbiota). An improvement in sur-
vival and growth after PHB administration was also found in blue mussel (Mytilus edulis) larvae59, Chinese mitten 
crab (Eriocheir sinensis) larvae60, giant tiger prawn (Penaeus monodon) post-larvae19 and sea bass juveniles21. It is 
hypothesized that PHB is gastrointestinally degraded into the SCFA β-HB (by digestive enzymes, PHB degrading 
bacteria or both), which promotes growth and survival by being an additional carbon source for the host16,61. 
SCFAs are known to be the main energy source of intestinal cells mediating their proliferation, differentiation 
and mucin production62. Moreover, SCFAs lower the intestinal pH, which may enhance the activity of digestive 
Microbial 
community 
parameters
Second sampling point (22 dph)
Control LMO LFF HMO HFF F p
Species richness 235 ± 25 268 ± 48 226 ± 13 272 ± 28 306 ± 8 0.3 0.86
Simpson’s evenness 0.04 ± 0.007 0.05 ± 0.009 0.04 ± 0.011 0.05 ± 0.014 0.03 ± 0.004 0.7 0.57
Inverse Simpson’s 
diversity 9 ± 1.8 12 ± 2.8 10 ± 2.4 16 ± 6.8 9 ± 1.4 0.7 0.59
Table 3. Microbial community parameters of sea bass larvae administered a low PHB dose from mouth 
opening onwards (LMO), a low PHB dose from first feeding onwards (LFF), a high PHB dose from mouth 
opening onwards (HMO), a high PHB dose from first feeding onwards (HFF) or no PHB (control), 
respectively. Values represent mean ± SEM. Furthermore, ANOVA results are shown (F-value, p-value, degrees 
of freedom/residual degrees of freedom for all parameters: 4/27).
Figure 4. Larval survival differs between PHB treatments upon bacterial challenge test. Kaplan-Meier survival 
curves of sea bass larvae challenged with V. anguillarum at 22 dph after being administered a low PHB dose 
from mouth opening onwards (LMO), a low PHB dose from first feeding onwards (LFF), a high PHB dose from 
mouth opening onwards (HMO), a high PHB dose from first feeding onwards (HFF) or no PHB (control), 
respectively. The dashed lines represent the 95% confidence intervals.
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enzymes leading to a better nutrient absorption63. This additional energy might be the reason for the observed 
enhanced survival in sea bass larvae provided with PHB.
The expression of 26 genes involved in the innate and adaptive immune response, the complement system, 
apoptosis, digestion, growth and oxidative damage was analyzed in order to estimate the effect of PHB on lar-
val immunity, metabolism and stress. It has to be noted that PHB was administered in form of freeze-dried 
(non-viable) PHB-accumulated bacteria and that a direct effect of these bacteria on the larval immune system 
cannot be excluded. However, previous studies using bacteria accumulated with different PHB doses showed that 
the level of PHB was most likely an important driver for the observed effects (e.g. disease resistance)19.
In the current study, the larval immune gene expression profiles differed significantly between the PHB treat-
ments at 11 and 22 dph, respectively. The analyses of individual genes revealed that this effect was only driven by 
a differential expression of the antimicrobial peptides ferritin (fer) and dicentracin (dic). This indicates that the 
observed changes in immune gene expressions are moderate and, therefore, cannot be detected for most indi-
vidual genes. The differences in the expression of fer and dic between the treatments did not show a consistent 
pattern as observed in sea bass post-larvae, where several immune-related genes were up-regulated in response 
to PHB administration30. However, it has to be taken into account that the methodological approach only allowed 
to analyze the expression of a limited number of genes (26) at 2 time points. Since the immune response in fish 
early life stages is mediated by a complex network of innate defense mechanisms3, it cannot be excluded that 
PHB may have induced changes in the expression of immune genes that were not assessed in this study. It was 
hypothesized that the metabolic product of PHB, the SCFA β-HB, might stimulate the immune system in fish in a 
similar way as in mammals by binding to G protein-coupled receptors (GPRs)29. Mammalian GPR43 for example 
recognizes butyrate and is highly expressed in macrophages and neutrophils64. Both cell types are known to be 
present already in fish early life stages65. The immune response might be triggered in addition through changes in 
the intestinal microbial community caused by the degradation of PHB lowering the luminal pH16. A lowered GI 
pH might result in the inhibition of virulence factor production and growth of pathogenic bacteria and promote 
the multiplication of specific beneficial bacteria, which can activate the humoral and cellular immune system 
through the recognition of microbe-associated molecular patterns (MAMPs) by pattern-recognition receptors 
(PRRs)57,66,67. In Siberian sturgeon larvae administered PHB from first-feeding onwards, the intestinal microbiota 
was altered68, however, the larval immune response was not examined. In the current study, the larva-associated 
bacterial phyla composition differed between the treatments indicating that PHB has the potential to trigger an 
immune response by altering the MAMPs (as described above). Interestingly, the treatment HMO, exhibiting 
the best survival and a trend towards an increased growth performance, had the highest proportion of bacteria 
belonging to the phylum Firmicutes. The phylum includes a variety of probiotic bacteria such as Bacillus spp. that 
have been demonstrated to confer a health benefit to the host15,57. The larval bacterial communities on the level 
of operational taxonomic units (OTUs) as well as the bacterial species richness, evenness and diversity were not 
affected by the administration of PHB. In contrast, the application of PHB increased the bacterial evenness and 
diversity in sea bass juveniles21,22 and Siberian sturgeon juveniles23. These results indicate that the mode of action 
of PHB might vary between different life cycle stages and, thus, depend on the maturity of the GI microbiota. 
However, since the microbiota could only be analyzed for a small number of replicates (due to an insufficient 
number of MiSeq reads for many larval samples), further microbiota analyses should be performed in future 
studies.
In previous studies, it was demonstrated that PHB increased disease resistance in aquatic organisms. Survival 
was enhanced when PHB was provided during bacterial challenge tests with axenic Nile tilapia larvae28, Chinese 
mitten crab larvae27 and Artemia24,26. It was concluded that PHB inhibited the multiplication of the pathogenic 
bacteria in the GI tract. SCFAs such as β-HB pass bacterial cell membranes and release protons in the cytoplasm, 
which have to be exported in order to maintain cellular homeostasis. This energy consuming process might sup-
press the growth of pathogenic bacteria16. In the current study, we investigated if the immunomodulating effects 
of PHB may increase the robustness of sea bass larvae during a V. anguillarum infection. In order to disentangle 
the immediate antimicrobial effect of the compound and its immunostimulatory capacities, sea bass larvae were 
not supplied with PHB during the bacterial challenge test. Compared to the control, none of the PHB treatments 
had a significant effect on the survival of sea bass larvae challenged with pathogenic bacteria which is the desired 
objective in commercial fish larviculture. In contrast, when shrimp (Penaeus monodon) post-larvae were infected 
with pathogenic bacteria after being fed with a PHB-supplemented diet, survival was increased compared to the 
control19. The divergent results obtained in sea bass larvae and shrimp post-larvae might be attributed to the 
different degrees of virulence of the bacteria used for the challenge tests. While over 75% of the Vibrio challenged 
sea bass larvae died in the control treatment (no PHB), less than 40% of the Vibrio challenged shrimp post-larvae 
died in the control treatment (no PHB). Therefore, the high virulence of the V. anguillarum strain used in the 
present study might have masked the potential protective effect of PHB. Furthermore, possible differences in the 
mode of action of PHB between teleost fish and crustaceans have to be taken into consideration and addressed 
in future studies.
In conclusion, our study indicates that administering amorphous PHB to sea bass larvae already before the 
onset of first feeding via the tank water had a positive influence on their survival. A prolongation of the time span 
of the PHB application is advised for further research to investigate if a significant growth-promoting effect can 
be obtained. The impact of PHB on the immune gene expression of sea bass yolk-sac larvae was inconsistent and 
weaker than detected in sea bass post-larvae30. During their first weeks of life, fish larvae undergo significant 
morphological and physiological changes including the maturation of the immune system. Thus, the mode of 
action of PHB in early, respectively, late larval stages might vary substantially. The current study highlights the 
need for more research focusing on the immunostimulation at different points in time during early development. 
In order to elucidate life-stage dependent differences, future studies on fish larvae analyzing an extended set of 
immune-related genes are necessary.
www.nature.com/scientificreports/
1 0SCIEnTIFIC RePoRts | 7: 15022  | DOI:10.1038/s41598-017-14785-z
References
 1. Conceição, L. E. C. et al. Novel methodologies in marine fish larval nutrition. Fish Physiol. Biochem. 36, 1–16 (2010).
 2. Valente, L. M. P. et al. What determines growth potential and juvenile quality of farmed fish species? Rev. Aquac. 5, 168–193 (2013).
 3. Vadstein, O. et al. Microbiology and immunology of fish larvae. Rev. Aquac. 4, 1–25 (2012).
 4. Hanif, A., Bakopoulos, V. & Dimitriadis, G. J. Maternal transfer of humoral specific and non-specific immune parameters to sea 
bream (Sparus aurata) larvae. Fish Shellfish Immunol. 17, 411–435 (2004).
 5. Swain, P. & Nayak, S. K. Role of maternally derived immunity in fish. Fish Shellfish Immunol. 27, 89–99 (2009).
 6. Tanaka, T., Furukawa, K., Suzuki, Y. & Aida, K. Transfer of maternal antibody from mother to egg may have no protective meaning 
for larvae of red sea bream Pagrus major, a marine teleost. Fish. Sci. 65, 240–243 (1999).
 7. Lillehaug, A., Sevatdal, S. & Endal, T. Passive transfer of specific maternal immunity does not protect Atlantic salmon (Salmo salar 
L.) fry against yersiniosis. Fish Shellfish Immunol. 6, 521–535 (1996).
 8. Breuil, G., Vassiloglou, B., Pepin, J. F. & Romestand, B. Ontogeny of IgM-bearing cells and changes in the immunoglobulin M-like 
protein level (IgM) during larval stages in sea bass (Dicentrarchus labrax). Fish Shellfish Immunol. 7, 29–43 (1997).
 9. Magnadottir, B., Lange, S., Gudmundsdottir, S., Bøgwald, J. & Dalmo, R. A. Ontogeny of humoral immune parameters in fish. Fish 
Shellfish Immunol. 19, 429–439 (2005).
 10. Magnadottír, B. Innate immunity of fish (overview). Fish Shellfish Immunol. 20, 137–151 (2006).
 11. Sommerset, I., Krossøy, B., Biering, E. & Frost, P. Vaccines for fish in aquaculture. Expert Rev. Vaccines 4, 89–101 (2005).
 12. Romero, J., Feijoó, C. G. & Navarrete, P. In Health and Environment in Aquaculture (ed. Carvalho, E.) 160–198, https://doi.
org/10.5772/28157 (Intech, 2012).
 13. Defoirdt, T., Sorgeloos, P. & Bossier, P. Alternatives to antibiotics for the control of bacterial disease in aquaculture. Curr. Opin. 
Microbiol. 14, 251–258 (2011).
 14. Ringø, E., Erik Olsen, R., Gonzalez Vecino, J. L. & Wadsworth, S. Use of immunostimulants and nucleotides in aquaculture: a review. 
J. Mar. Sci. Res. Dev. 2, 1–22 (2011).
 15. Akhter, N., Wu, B., Memon, A. M. & Mohsin, M. Probiotics and prebiotics associated with aquaculture: A review. Fish Shellfish 
Immunol. 45, 733–741 (2015).
 16. Defoirdt, T., Boon, N., Sorgeloos, P., Verstraete, W. & Bossier, P. Short-chain fatty acids and poly-β-hydroxyalkanoates: (New) 
Biocontrol agents for a sustainable animal production. Biotechnol. Adv. 27, 680–685 (2009).
 17. Suriyamongkol, P., Weselake, R., Narine, S., Moloney, M. & Shah, S. Biotechnological approaches for the production of 
polyhydroxyalkanoates in microorganisms and plants — A review. Biotechnol. Adv. 25, 148–175 (2007).
 18. Wang, B., Sharma-Shivappa, R. R., Olson, J. W. & Khan, S. A. Upstream process optimization of polyhydroxybutyrate (PHB) by 
Alcaligenes latus using two-stage batch and fed-batch fermentation strategies. Bioprocess Biosystesms Eng. 35, 1591–1602 (2012).
 19. Laranja, J. L. Q. et al. Poly-β-hydroxybutyrate (PHB) accumulating Bacillus spp. improve the survival, growth and robustness of 
Penaeus monodon (Fabricius, 1798) postlarvae. Vet. Microbiol. 173, 310–317 (2014).
 20. Najdegerami, E. H. et al. Dietary effects of poly-β-hydroxybutyrate on the growth performance, digestive enzyme activity, body 
composition, mineral uptake and bacterial challenge of rainbow trout fry (Oncorhynchus mykiss). Aquac. Nutr. 23, 246–254 (2015).
 21. De Schryver, P. et al. Poly-β-hydroxybutyrate (PHB) increases growth performance and intestinal bacterial range-weighted richness 
in juvenile European sea bass, Dicentrarchus labrax. Appl. Microbiol. Biotechnol. 86, 1535–1541 (2010).
 22. De Schryver, P. et al. Convergent dynamics of the juvenile European sea bass gut microbiota induced by poly-ß-hydroxybutyrate. 
Environ. Microbiol. 13, 1042–1051 (2011).
 23. Najdegerami, E. H. et al. Effects of poly-β-hydroxybutyrate (PHB) on Siberian sturgeon (Acipenser baerii) fingerlings performance 
and its gastrointestinal tract microbial community. FEMS Microbiol. Ecol. 79, 25–33 (2012).
 24. Defoirdt, T. et al. The bacterial storage compound poly-ß-hydroxybutyrate protects Artemia franciscana from pathogenic Vibrio 
campbellii. Environ. Microbiol. 9, 445–452 (2007).
 25. Cotter, P. D. & Hill, C. Surviving the acid test: Responses of gram-positive bacteria to low pH. Microbiol. Mol. Biol. Rev. 67, 429–453 (2003).
 26. Baruah, K. et al. Probing the protective mechanism of poly-ß-hydroxybutyrate against vibriosis by using gnotobiotic Artemia 
franciscana and Vibrio campbellii as host-pathogen model. Sci. Rep. 5, 1–8 (2015).
 27. Sui, L., Cai, J., Sun, H., Wille, M. & Bossier, P. Effect of poly-β-hydroxybutyrate on Chinese mitten crab, Eriocheir sinensis, larvae 
challenged with pathogenic Vibrio anguillarum. J. Fish Dis 35, 359–364 (2012).
 28. Situmorang, M. L., De Schryver, P., Dierckens, K. & Bossier, P. Effect of poly-ß-hydroxybutyrate on growth and disease resistance of 
Nile tilapia Oreochromis niloticus juveniles. Vet. Microbiol. 182, 44–49 (2016).
 29. Montalban-Arques, A. et al. Selective manipulation of the gut microbiota improves immune status in vertebrates. Front. Immunol. 
6, 1–14 (2015).
 30. Franke, A. et al. Immunostimulatory effects of dietary poly-β-hydroxybutyrate in European sea bass post-larvae. Aquac. Res. 00, 
1–11 (2017).
 31. Suguna, P. et al. Immunostimulation by poly-β hydroxybutyrate-hydroxyvalerate (PHB-HV) from Bacillus thuringiensis in 
Oreochromis mossambicus. Fish Shellfish Immunol. 36, 90–97 (2014).
 32. Saillant, E., Fostier, A., Haffray, P., Menu, B. & Chatain, B. Saline preferendum for the European sea bass, Dicentrarchus labrax, larvae 
and juveniles: Effect of salinity on early development and sex determination. J. Exp. Mar. Bio. Ecol. 287, 103–117 (2003).
 33. Thai, T. Q. et al. Poly-β-hydroxybutyrate content and dose of the bacterial carrier for Artemia enrichment determine the 
performance of giant freshwater prawn larvae. Appl. Microbiol. Biotechnol. 98, 5205–5215 (2014).
 34. Mitter, K. et al. Evaluation of candidate reference genes for QPCR during ontogenesis and of immune-relevant tissues of European 
seabass (Dicentrarchus labrax). Comp. Biochem. Physiol. - B Biochem. Mol. Biol. 153, 340–347 (2009).
 35. Sarropoulou, E. et al. Profiling of infection specific mRNA transcripts of the European seabass Dicentrarchus labrax. BMC Genomics 
10, 1–18 (2009).
 36. Caporaso, J. G. et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. PNAS 108, 4516–4522 
(2011).
 37. Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K. & Schloss, P. D. Development of a dual-index sequencing strategy and 
curation pipeline for analyzing amplicon sequence data on the miseq illumina sequencing platform. Appl. Environ. Microbiol. 79, 
5112–5120 (2013).
 38. Pruesse, E. et al. SILVA: A comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible 
with ARB. Nucleic Acids Res. 35, 7188–7196 (2007).
 39. Huse, S. M., Welch, D. M., Morrison, H. G. & Sogin, M. L. Ironing out the wrinkles in the rare biosphere through improved OTU 
clustering. Environ. Microbiol. 12, 1889–1898 (2010).
 40. Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. 
Bioinformatics 27, 2194–2200 (2011).
 41. Cole, J. R. et al. The Ribosomal Database Project (RDP-II): Sequences and tools for high-throughput rRNA analysis. Nucleic Acids 
Res. 33, 294–296 (2005).
 42. Therneau, T. Package Survival: A Package for Survival Analysis in R. R Packag. version 2, 38 (2015).
 43. Bates, D., Mächler, M., Bolker, B. & Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, 1–48 (2015).
 44. Bookout, A. L. & Mangelsdorf, D. J. Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl. 
Recept. Signal. 1, (1–7 (2003).
www.nature.com/scientificreports/
1 1SCIEnTIFIC RePoRts | 7: 15022  | DOI:10.1038/s41598-017-14785-z
 45. Oksanen, J., Blanchet, F. G. & Kindt, R. Package Vegan: Community Ecology Package. R package version 2, 0–3 (2012).
 46. Lucas, A. Package amap: Another Multidimensional Analysis Package. R Packag. version 0, 8–7 (2011).
 47. Lenth, R. V. L.-S. M. The {R} Package {lsmeans}. J. Stat. Softw. 69, 1–33 (2016).
 48. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. 
Methods 25, 402–408 (2001).
 49. Wang, J. et al. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck 
identifies a novel metastatic phenotype. Cancer Res. 64, 1861–1866 (2004).
 50. Dray, S. & Dufour, A. B. The ade4 package: implementing the duality diagram for ecologists. J. Stat. Softw. 22, 1–20 (2007).
 51. R Core Team. R: A language and environment for statistical computing. (2016).
 52. Rosenthal, H. & Alderdice, D. F. Sublethal effects of environmental stressors, natural and pollutional, on marine fish eggs and larvae. 
J. Fish. Res. Board Canada 33, 2047–2065 (1976).
 53. Pepin, P. Effect of temperature and size on development, mortality, and survival rates of the pelagic early life history stages of marine 
fish. Can. J. Fish. Aquat. Sci. 48, 503–518 (1991).
 54. Voss, R., Hinrichsen, H. H. & Wieland, K. Model-supported estimation of mortality rates in Baltic cod (Gadus morhua callarias L.) 
larvae: the varying impact of ‘critical periods’. BMC Ecol. 1, 1–10 (2001).
 55. Castro, R. et al. Disparate developmental patterns of immune responses to bacterial and viral infections in fish. Sci. Rep. 5, 1–12 (2015).
 56. Maynard, C. L., Elson, C. O., Hatton, R. D. & Weaver, C. T. Reciprocal interactions of the intestinal microbiota and immune system. 
Nature 489, 231–241 (2012).
 57. Gómez, G. D. & Balcázar, J. L. A review on the interactions between gut microbiota and innate immunity of fish. FEMS Immunol. 
Med. Microbiol. 52, 145–154 (2008).
 58. Hatziathanasiou, A. et al. Survival, growth and feeding in early life stages of European sea bass (Dicentrarchus labrax) intensively 
cultured under different stocking densities. Aquaculture 205, 89–102 (2002).
 59. Hung, N. V. et al. Application of poly-β-hydroxybutyrate (PHB) in mussel larviculture. Aquaculture 446, 318–324 (2015).
 60. Sui, L. et al. The effect of poly-ß-hydroxybutyrate on the performance of Chinese mitten crab (Eriocheir sinensis Milne-Edwards) 
zoea larvae. Aquac. Res. 45, 558–565 (2014).
 61. Weltzien, F. A., Hemre, G. I., Evjemo, J. O., Olsen, Y. & Fyhn, H. J. β-Hydroxybutyrate in developing nauplii of brine shrimp (Artemia 
franciscana K.) under feeding and non-feeding conditions. Comp. Biochem. Physiol. - B Biochem. Mol. Biol. 125, 63–69 (2000).
 62. Roy, C. C., Kien, C. L., Bouthillier, L. & Levy, E. Short-chain fatty acids: ready for prime time? Nutr. Clin. Pract. 21, 351–366 (2015).
 63. Lückstädt, C. The use of acidifiers in fisheries and aquaculture. CAB Rev. Perspect. Agric. Vet. Sci. Nutr. Nat. Resour. 3, 1–8 (2008).
 64. Brestoff, J. R. & Artis, D. Commensal bacteria at the interface of host metabolism and the immune system. Nat. Immunol. 14, 
676–684 (2013).
 65. Rombout, J. H. W. M., Huttenhuis, H. B. T., Picchietti, S. & Scapigliati, G. Phylogeny and ontogeny of fish leucocytes. Fish Shellfish 
Immunol. 19, 441–455 (2005).
 66. Sekirov, I. & Finlay, B. B. The role of the intestinal microbiota in enteric infection. J. Physiol. 587, 4159–4167 (2009).
 67. Magnadottir, B. Immunological control of fish diseases. Mar. Biotechnol. 12, 361–379 (2010).
 68. Najdegerami, E. H. et al. Siberian sturgeon (Acipenser baerii) larvae fed Artemia nauplii enriched with poly-ß-hydroxybutyrate 
(PHB): effect on growth performance, body composition, digestive enzymes, gut microbial community, gut histology and stress 
tests. Aquac. Res. 46, 801–812 (2015).
Acknowledgements
This work was part of the FINEAQUA-project (grant number 12212001) funded by the Program for the Future 
- Economy (financed by the European Regional Development Fund, the Federal Republic of Germany and 
the state of Schleswig-Holstein). Olivia Roth was supported by Deutsche Forschungsgemeinschaft (DFG) and 
VolkswagenStiftung. Peter De Schryver was supported as a postdoctoral fellow by the Research Fund - Flanders 
(FWO), Belgium. The authors would like to thank Fabian Wendt for his excellent technical support and Anne 
Beemelmanns, Franziska Brunner and Isabel Keller for statistical advice. Additionally, we would like to thank 
Ramona Beckmann, Markus Franz, Martina Stiasny, Hanna Schade, Maude Poirier and Kerstin Nachtigall for 
their help during the experiment and in the laboratory. Especially Robert Tillner is thanked for sharing his 
knowledge on fish larval rearing.
Author Contributions
The experiment was designed by A.F., C.C. and O.R. and was conducted by A.F. and J.J.M. The PHB-containing 
bacteria were provided by L.G.C. The samples were analyzed by A.F., J.J.M. and S.K. The data were analyzed by 
A.F., J.J.M., T.B., P.D.S. and O.R. A.F. wrote the manuscript, including all figures, tables and statistical analyses 
assisted by O.R., T.B., J.J.M., C.C., P.B. and P.D.S. All authors reviewed the manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-017-14785-z.
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
